Literature DB >> 20660289

Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.

Poonam Tewary1, De Yang, Gonzalo de la Rosa, Yana Li, Michael W Finn, Alan M Krensky, Carol Clayberger, Joost J Oppenheim.   

Abstract

Granulysin (GNLY), an antimicrobial protein present in the granules of human cytotoxic T lymphocytes and natural killer (NK) cells, is produced as an intact 15-kDa form that is cleaved to yield a 9-kDa form. Alarmins are endogenous mediators that can induce recruitment and activation of antigen-presenting cells (APCs) and consequently promote the generation of immune response. We hypothesized that GNLY might function as an alarmin. Here, we report that both 9- and 15-kDa forms of recombinant GNLY-induced in vitro chemotaxis and activation of both human and mouse dendritic cells (DCs), recruited inflammatory leucocytes, including APCs in mice, and promoted antigen-specific immune responses upon coadministration with an antigen. GNLY-induced APC recruitment and activation required the presence of Toll-like receptor 4. The observed activity of recombinant GNLY was not due to endotoxin contamination. The capability of the supernatant of GNLY-expressing HuT78 cells to activate DC was blocked by anti-GNLY antibodies. Finally we present evidence that supernatants of degranulated human NK92 or primary NK cells also activated DCs in a GNLY- and Toll-like receptor 4-dependent manner, indicating the physiologic relevance of our findings. Thus, GNLY is the first identified lymphocyte-derived alarmin capable of promoting APC recruitment, activation, and antigen-specific immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660289      PMCID: PMC2981473          DOI: 10.1182/blood-2010-03-273953

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses.

Authors:  Amer A Beg
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

2.  Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1.

Authors:  Yutaka Kida; Takashi Shimizu; Koichi Kuwano
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

3.  Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer.

Authors:  Atsuko Kishi; Yasushi Takamori; Kazuyuki Ogawa; Shoichi Takano; Shuji Tomita; Mari Tanigawa; Makiko Niman; Tsunataro Kishida; Setsuya Fujita
Journal:  Cancer Immunol Immunother       Date:  2001-11-22       Impact factor: 6.968

4.  Granulysin crystal structure and a structure-derived lytic mechanism.

Authors:  Daniel H Anderson; Michael R Sawaya; Duilio Cascio; William Ernst; Robert Modlin; Alan Krensky; David Eisenberg
Journal:  J Mol Biol       Date:  2003-01-10       Impact factor: 5.469

5.  CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15.

Authors:  Ling Ling Ma; Jason C L Spurrell; Jian Fei Wang; Graham G Neely; Slava Epelman; Alan M Krensky; Christopher H Mody
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

Review 6.  Granulysin.

Authors:  Carol Clayberger; Alan M Krensky
Journal:  Curr Opin Immunol       Date:  2003-10       Impact factor: 7.486

7.  Granulysin in human serum as a marker of cell-mediated immunity.

Authors:  Kazuyuki Ogawa; Yasushi Takamori; Kunou Suzuki; Masayuki Nagasawa; Shoichi Takano; Yoshihito Kasahara; Yoshiko Nakamura; Shigemi Kondo; Kazuo Sugamura; Masataka Nakamura; Kinya Nagata
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

8.  Sr++-induced inhibition of human natural killer (NK) cell-mediated cytotoxicity.

Authors:  P A Neighbour; H S Huberman
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

9.  Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection.

Authors:  Katja Kotsch; Mir Farzin Mashreghi; Gantuja Bold; Philipp Tretow; Jana Beyer; Mareen Matz; Jan Hoerstrup; Johann Pratschke; Ruchuang Ding; Manikkam Suthanthiran; Hans-Dieter Volk; Petra Reinke
Journal:  Transplantation       Date:  2004-06-27       Impact factor: 4.939

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  48 in total

1.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

2.  In vivo potential of recombinant granulysin against human tumors.

Authors:  Sameer Al-Wasaby; Diego de Miguel; Adriana Aporta; Javier Naval; Blanca Conde; Luis Martínez-Lostao; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

3.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

Review 4.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

5.  Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis.

Authors:  J Ma; J Lu; H Huang; X Teng; M Tian; Q Yu; X Yuan; Y Jing; C Shi; J Li; X Fan
Journal:  Gene Ther       Date:  2015-07-16       Impact factor: 5.250

6.  Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.

Authors:  Kun Taek Park; Andrew J Allen; John P Bannantine; Keun Seok Seo; Mary J Hamilton; Gaber S Abdellrazeq; Heba M Rihan; Amanda Grimm; William C Davis
Journal:  Vaccine       Date:  2011-05-10       Impact factor: 3.641

Review 7.  Crohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue.

Authors:  William C Davis; Sally A Madsen-Bouterse
Journal:  Vet Immunol Immunopathol       Date:  2011-12-14       Impact factor: 2.046

Review 8.  Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?

Authors:  M H J van den Bosch
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

Review 9.  Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.

Authors:  Ângela C Crespo; Anita van der Zwan; João Ramalho-Santos; Jack L Strominger; Tamara Tilburgs
Journal:  J Reprod Immunol       Date:  2016-08-02       Impact factor: 4.054

10.  Granule exocytosis of granulysin and granzyme B as a potential key mechanism in vaccine-induced immunity in cattle against the nematode Ostertagia ostertagi.

Authors:  Frederik Van Meulder; Stefanie Van Coppernolle; Jimmy Borloo; Manuela Rinaldi; Robert W Li; Koen Chiers; Wim Van den Broeck; Jozef Vercruysse; Edwin Claerebout; Peter Geldhof
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.